Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

40.166%

Threshold

Crossed downwards

Timeline

Published

15.01.2026

Transaction

08.01.2026

Transfer date

15.01.2026

Voting rights breakdown

Voting rights acquired4.72%
Voting rights sold40.166%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

ZA01-000000000RJG3

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln, CH

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open